Molecular Partners AG
MOLN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -29.4% | -96.3% | 1,931.7% | – |
| Gross Profit | -$0 | -$0 | $0 | -$0 |
| % Margin | -855.8% | -579.8% | 73.2% | -497.2% |
| EBITDA | -$0 | -$0 | $0 | -$0 |
| % Margin | -1,039.2% | -845.6% | 62.8% | -650.2% |
| Net Income | -$0 | -$0 | $0 | -$0 |
| % Margin | -1,087.4% | -880.7% | 62.2% | -683.7% |
| EPS Diluted | -1.59 | -1.89 | 3.54 | -2.06 |
| % Growth | 15.9% | -153.4% | 271.8% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | -$0 |